Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/29/2005WO2005123190A1 Ultrasonic treatment of skin conditions or disorders, cancer as well as muscular/skeletal regeneration
12/29/2005WO2005123125A1 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
12/29/2005WO2005123121A2 Use of dna molecule as vaccine adjuvant
12/29/2005WO2005123110A2 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
12/29/2005WO2005123109A2 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use
12/29/2005WO2005123107A2 Immune response suppressor and treatment of multiple sclerosis
12/29/2005WO2005123104A2 Use of vegf inhibitors for the treatment of human cancer
12/29/2005WO2005122751A1 Nucleic acid molecules and their use in plant male sterility
12/29/2005WO2005122739A2 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus
12/29/2005WO2005122712A2 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide
12/29/2005WO2005122697A2 Transgenic plants containing a dehydrin gene
12/29/2005WO2005122675A2 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins
12/29/2005WO2005103268A3 Generation of plants with altered oil content
12/29/2005WO2005098009A3 Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
12/29/2005WO2005074436A3 Self-assembling split-fluorescent protein systems
12/29/2005WO2005072270A3 Methods and compositons for treating cancer
12/29/2005WO2005066202A3 Bacillus cry9 family members
12/29/2005WO2005065309A3 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer
12/29/2005WO2005063802A3 Haemophilus influenzae type iv pili
12/29/2005WO2005059505A3 Method and kit for the genotypification of hla-b27 based on real time pcr
12/29/2005WO2005053516A3 Replication competent hepatitis c virus and methods of use
12/29/2005WO2005051975A3 Methods for obtaining molecules with reduced immunogenicity
12/29/2005WO2005049806A3 Novel nucleic acids and polypeptides
12/29/2005WO2005049790A3 Skn-1 and gsk-3 genes and proteins
12/29/2005WO2005046587A3 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
12/29/2005WO2005042698A3 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same
12/29/2005WO2005040353A3 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv
12/29/2005WO2005040352A3 Immunogenic composition and method of developing a vaccine based on factor h binding sites
12/29/2005WO2005037190A3 Multiplex vaccines
12/29/2005WO2005034881A3 Methods and compositions for treating conditions involving abnormal angiogenesis
12/29/2005WO2005033139A3 Novel calcium channels and uses thereof
12/29/2005WO2005028614A3 Construction of a gst-cbd fusion protein having several enzymatic activities
12/29/2005WO2005023996A3 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
12/29/2005WO2005021034A3 Safe mutant viral vaccines
12/29/2005WO2005020889A3 Functional influenza virus-like particles (vlps)
12/29/2005WO2005019411A3 Ancestral viruses and vaccines
12/29/2005WO2005013918A3 Compositions, methods and kits relating to poxvirus subunit vaccines
12/29/2005WO2004111608A8 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/29/2005WO2004103269A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
12/29/2005WO2004074437A3 Compositions and methods for cancer immunotherapy
12/29/2005WO2004069166A3 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
12/29/2005WO2004045544A8 Autocrine growth factor receptor antibodies and methods
12/29/2005WO2004037992A3 Mapk7 as modifier of branching morphogenesis and methods of use
12/29/2005WO2004033659A3 Novel tumor suppressor gene and compositions and methods for making and using the same
12/29/2005WO2004021861A3 Targeted release
12/29/2005WO2004015073A3 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/29/2005WO2003072799A3 Brother of the regulator of imprinted sites (boris)
12/29/2005WO2003071933A3 Novel compositions and methods for cancer
12/29/2005WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
12/29/2005WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer
12/29/2005WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use
12/29/2005WO2002033113A3 Protein-protein interactions in neurodegenerative diseases
12/29/2005US20050289671 Materials and methods for producing geminivirus resistant plants
12/29/2005US20050289666 Starch-inducible promoters, recombinant gene constructs, and methods of regulating gene expression
12/29/2005US20050289661 CXCR6 chemokine receptor gene disruptions, and compositions and methods related thereto
12/29/2005US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
12/29/2005US20050289058 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
12/29/2005US20050288498 Novel human ion channel-related proteins and polynucleotides encoding the same
12/29/2005US20050288490 Polyether with glycerol backbone; capable of being labeled
12/29/2005US20050288489 Voltage-dependent calcium channel beta subunit functional core
12/29/2005US20050288488 Ah receptor cDNA and genetically engineered cells for detecting agonists to the Ah receptor
12/29/2005US20050288487 Human mast cell-expressed membrane proteins
12/29/2005US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
12/29/2005US20050288247 Inducible inactivation of synaptic transmission
12/29/2005US20050288241 encoding novel polypeptides, called "NOVX" nucleic acid sequences; vectors and host cells; wide variety of therapeutic and diagnostic uses; drug targets or therapeutic use; encode proteins such as NOV15 of the MEGF/Fibrillin family of proteins which have epidermal growth factor (EGF)-like motifs
12/29/2005US20050288229 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants
12/29/2005US20050288226 Administering to a cancer cell exhibiting reduced WIF-1 expression an effective amount of a polypeptide operably linked to a signal sequence or fused to a heterologous amino acid sequence, wherein said administering inhibits cancer cell proliferation
12/29/2005US20050288225 Modulators of intracellular inflammation, cell death and cell survival pathways
12/29/2005US20050288224 Novel protein, a gene coding therefor and a method of using the same
12/29/2005US20050288223 OBG3 Fragments Inhibiting The Conversion Of Active OBG3 Into Less Active OBG3 And Other Compositions For Treatment Of Metabolic Disorders
12/29/2005US20050288220 Erythropoietin with high specific activity
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050288218 Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
12/29/2005US20050288217 Method for enhancing or inhibiting insulin-like growth factor-I
12/29/2005US20050288214 Nucleotide sequence encoding PTD and CEA fusion protein, Tat-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein
12/29/2005US20050288212 Components of the presenilin-complex
12/29/2005US20050287671 Soluble steroidal peptides for nucleic acid delivery
12/29/2005US20050287669 Nucleic acid construct and expression vector for enhancing the production of recombinant protein, and method for the massive production of recombinant protein
12/29/2005US20050287663 DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor
12/29/2005US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
12/29/2005US20050287643 Protein binding miniature proteins and uses thereof
12/29/2005US20050287642 Efficient protein expression system
12/29/2005US20050287641 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin
12/29/2005US20050287640 Human spasmolytic polypeptide in glycosylated form
12/29/2005US20050287639 Methods of incorporating amino acid analogs into proteins
12/29/2005US20050287638 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents
12/29/2005US20050287636 Polypeptide; low density lipoprotein antioxidant, efficient delivery of cholesterol to hepatocytes
12/29/2005US20050287635 RTD receptor
12/29/2005US20050287633 Vanilloid receptor
12/29/2005US20050287632 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex
12/29/2005US20050287631 Compositions and methods related to a dimeric MHC class I and II-Like molecule (dsMHCI and dsMHCII)
12/29/2005US20050287627 In presence of ATP and peptidases
12/29/2005US20050287622 A peptide substrate for use as site of botulinum or tetnaus neurotoxin protease action and in identifying modulator which inhibit neurotoxic activity; prevention and treatment of food poisoning; fluorescence resonant energy transfer assay
12/29/2005US20050287618 Labeling or detecting of immobilized poly(amino acids), including peptides, polypeptides and proteins, on membranes and other solid supports;
12/29/2005US20050287612 CARD-4 molecules and uses thereof
12/29/2005US20050287608 Diagnostic methods for protein profiling
12/29/2005US20050287606 T1 receptor-like ligand I
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287602 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell
12/29/2005US20050287598 specific, high flow-through, and cost-effective assay for testing sample materials for the presence of a pathogenic protein including transthyretin and prion protein; sample is treated with a compound, e.g. a metalloendopeptidase, which selectively hydrolyzes prion protein but not abnormal form
1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 2916